.

Pharmaceutical Business Intelligence

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Dronabinol - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for dronabinol?

Dronabinol is the generic ingredient in two branded drugs marketed by Insys Therap, Akorn Inc, Abbvie, and Svc Pharma, and is included in four NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for dronabinol. Seven suppliers are listed for this compound.

Summary for Generic Name: dronabinol

Tradenames:2
Patents:1
Applicants:4
NDAs:4
Drug Master File Entries: see list11
Suppliers / Packagers: see list7
Bulk Api Vendors: see list15
Clinical Trials: see list18
Patent Applications: see list5,665
Therapeutic Class:Antiemetics
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:dronabinol at DailyMed

Pharmacology for Ingredient: dronabinol

Ingredient-typeCannabinoids
Drug ClassCannabinoid
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn Inc
DRONABINOL
dronabinol
CAPSULE;ORAL079217-003Jun 20, 2014RXNoNo► Subscribe► Subscribe
Insys Therap
DRONABINOL
dronabinol
CAPSULE;ORAL078501-003Aug 19, 2011DISCNNoNo► Subscribe► Subscribe
Insys Therap
DRONABINOL
dronabinol
CAPSULE;ORAL078501-002Aug 19, 2011DISCNNoNo► Subscribe► Subscribe
Akorn Inc
DRONABINOL
dronabinol
CAPSULE;ORAL079217-002Jun 20, 2014RXNoNo► Subscribe► Subscribe
Abbvie
MARINOL
dronabinol
CAPSULE;ORAL018651-002May 31, 1985RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: dronabinol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie
MARINOL
dronabinol
CAPSULE;ORAL018651-001May 31, 19856,703,418► Subscribe
Abbvie
MARINOL
dronabinol
CAPSULE;ORAL018651-002May 31, 19856,703,418► Subscribe
Abbvie
MARINOL
dronabinol
CAPSULE;ORAL018651-003May 31, 19856,703,418► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc